# Positron Emission Tomography of Amyloid in Alzheimer's Disease

> **NCT00205621** · PHASE1 · SUSPENDED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 50 (—)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DEVICE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT00205621
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205621, "Positron Emission Tomography of Amyloid in Alzheimer's Disease". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00205621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*